Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention

NCT02508116 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

509

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Cardiovascular Diseases

Interventions

GENETIC: CYP2C19 genotyping

Sponsor

University of Pennsylvania